COMMONLY REPORTED ADVERSE EVENTS ASSOCIATED WITH ANTICOAGULANTS USING FDA ADVERSE EVENT REPORTING SYSTEM DATABASE 2012-2018

被引：0
|
作者：
Costa, L. [1 ]
Hincapie, A. [1 ]
Guo, J. J. [1 ]
机构：
[1] Univ Cincinnati, Cincinnati, OH USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.684
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDG5
引用
收藏
页码：S163 / S163
页数：1
相关论文
共 50 条
  • [41] Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system
    Shu, Yamin
    He, Xucheng
    Wu, Pan
    Liu, Yanxin
    Ding, Yufeng
    Zhang, Qilin
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [42] Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system
    Pan, Xianglin
    Xiao, Xiangtian
    Ding, Yiling
    Shu, Yamin
    Zhang, Wenting
    Huang, Liu
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [43] A disproportionality analysis of adverse events associated with loop diuretics in the FDA Adverse Event Reporting System (FAERS)
    Xue, Zehu
    Liu, Xi
    Liu, Qifeng
    Yang, Xiuming
    Yu, Lixia
    BMC PHARMACOLOGY & TOXICOLOGY, 2025, 26 (01):
  • [44] Adverse events associated with azithromycin and clarithromycin in adults aged ≥65: a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database
    Zhang, Zhenpo
    He, Jiaxin
    Liang, Yankun
    Wang, Yuting
    Zheng, Jingping
    Ma, Lin
    Su, Ling
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [45] Drug Repurposing Using FDA Adverse Event Reporting System (FAERS) Database
    Morris, Robert
    Ali, Rahinatu
    Cheng, Feng
    CURRENT DRUG TARGETS, 2024, 25 (07) : 454 - 464
  • [46] Cardiovascular thromboembolic events associated with febuxostat: Investigation of cases from the FDA adverse event reporting system database
    Gandhi, Pranav K.
    Gentry, William M.
    Bottorff, Michael B.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2013, 42 (06) : 562 - 566
  • [47] Signal detection for adverse events of dapagliflozin using the Korea adverse event reporting system database
    Park, Suvin
    Lee, Huieon
    Kim, Hee-Jin
    Jeong, Na-Young
    Lim, Eunsun
    Choi, Nam-Kyong
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 597 - 597
  • [48] Comparative Analysis of Psychiatric Adverse Events of Brivaracetam and Levetiracetam Using the FDA Adverse Event Reporting System
    Porwal, Mokshal H.
    Shah, Ipsit
    Shah, Aneri N.
    Obeidat, Ahmed Z.
    ANNALS OF NEUROLOGY, 2022, 92 : S87 - S88
  • [49] Neuropsychiatric adverse events of chloroquine: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database
    Sato, Kenichiro
    Mano, Tatsuo
    Iwata, Atsushi
    Toda, Tatsushi
    BIOSCIENCE TRENDS, 2020, 14 (02) : 139 - 143
  • [50] Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
    Wen, Ming-Tao
    Li, Jia-Cheng
    Lu, Bo-Wen
    Shao, Hua-Rong
    Ling, Pei-Xue
    Liu, Fei
    Li, Gang
    Luo, Di
    FRONTIERS IN PHARMACOLOGY, 2024, 15
12345